ASSET | DATE | % RETURN |
---|---|---|
P3 Health Partners (PIII) | 4/13/2023 - 5/30/2023 | 270.18% |
Corvus Pharmaceuticals (CRVS) | 4/13/2023 - 5/30/2023 | 178.38% |
Nano X Imaging (NNOX) | 4/13/2023 - 5/30/2023 | 176.95% |
Bioventus (BVS) | 4/13/2023 - 5/30/2023 | 155.26% |
Ads Tec Energy (ADSE) | 4/13/2023 - 5/30/2023 | 146.12% |
SS Innovations International Inc Common Stock (SSII) | 4/13/2023 - 5/30/2023 | 120.63% |
Bit Digital (BTBT) | 4/13/2023 - 5/30/2023 | 91.23% |
Microvision (MVIS) | 4/13/2023 - 5/30/2023 | 89.79% |
Evolv Technologies (EVLV) | 4/13/2023 - 5/30/2023 | 86.38% |
MiMedx (MDXG) | 4/13/2023 - 5/30/2023 | 82.59% |
Aquestive Therapeutics (AQST) | 4/13/2023 - 5/30/2023 | 82.3% |
Organogenesis (ORGO) | 4/13/2023 - 5/30/2023 | 81.82% |
Arteris (AIP) | 4/13/2023 - 5/30/2023 | 79.26% |
Autolus Therapeutics (AUTL) | 4/13/2023 - 5/30/2023 | 78.33% |
SEALSQ (LAES) | 4/13/2023 - 5/30/2023 | 74.53% |
Eyepoint Pharmaceuticals (EYPT) | 4/13/2023 - 5/30/2023 | 73.29% |
Edgewise Therapeutics (EWTX) | 4/13/2023 - 5/30/2023 | 68.98% |
Latham (SWIM) | 4/13/2023 - 5/30/2023 | 68.7% |
NRx Pharmaceuticals (NRXPW) | 4/13/2023 - 5/30/2023 | 66.67% |
Geron (GERN) | 4/13/2023 - 5/30/2023 | 66% |
Immatics (IMTX) | 4/13/2023 - 5/30/2023 | 64.86% |
Ideaya Biosciences (IDYA) | 4/13/2023 - 5/30/2023 | 63.01% |
American Coastal Insurance (ACIC) | 4/13/2023 - 5/30/2023 | 62.98% |
Iovance Biotherapeutics (IOVA) | 4/13/2023 - 5/30/2023 | 62.68% |
Weave Communications (WEAV) | 4/13/2023 - 5/30/2023 | 61.69% |